Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis Veronica RavanoGian Franco PireddaManuela Vaneckova Original Communication Open access 11 October 2023 Pages: 631 - 641
Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension Ludwig KapposAnthony TraboulseeStephen L. Hauser Original Communication Open access 31 October 2023 Pages: 642 - 657
Peering further into the mind’s eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis Thomas J. CoveyDaniel GolanMark Gudesblatt Original Communication 13 December 2023 Pages: 658 - 673
Multiple sclerosis in the elderly: a retrospective cohort study Anne ZinganellGeorg GöbelFlorian Deisenhammer Original Communication 19 October 2023 Pages: 674 - 687
Emotional burden among MS patients: associations between specific chronic pain diagnoses and psychological features Michal RivelAnat AchironRuth Defrin Original Communication 24 October 2023 Pages: 688 - 698
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients Alvino BiseccoFederica Matronethe OCREVID study group on behalf of the Italian MS Register Original Communication Open access 20 November 2023 Pages: 699 - 710
Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium Dejan JakimovskiKatelyn S. Kavakthe New York State Multiple Sclerosis Consortium (NYSMSC) Original Communication 23 November 2023 Pages: 711 - 722
Rasmussen’s syndrome treated with anakinra Abdullah ArcanEsra Koçhan KızılkılıçÇiğdem Özkara Short Commentary 03 November 2023 Pages: 723 - 726
Serum sickness in a multiple sclerosis patient treated with ocrelizumab Vittorio ManteroChristian CordanoAndrea Salmaggi Letter to the Editors 31 October 2023 Pages: 727 - 728
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod Lina JeantinNatalia ShorValérie Pourcher Letter to the Editors 01 November 2023 Pages: 729 - 732
Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts Laynie DratchMeron AzageColin A. Ellis Review 27 October 2023 Pages: 733 - 747
AMPK role in epilepsy: a promising therapeutic target? Yingbei QiYong-mei ZhangJia Li Review 27 November 2023 Pages: 748 - 771
Relationships between intracranial arterial dolichoectasia and small vessel disease in patients with ischaemic stroke: a systematic review and meta-analysis Kitti ThiankhawHatice OzkanDavid J. Werring Review Open access 29 November 2023 Pages: 772 - 781
The comorbidity and co-medication profile of patients with progressive supranuclear palsy Stephan GretenFlorian WegnerMartin Klietz Original Communication Open access 06 October 2023 Pages: 782 - 793
The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis Francesco GentileAlessio MaranzanoNicola Ticozzi Original Communication Open access 06 October 2023 Pages: 794 - 803
Implementation of a 7T Epilepsy Task Force consensus imaging protocol for routine presurgical epilepsy work-up: effect on diagnostic yield and lesion delineation Gilbert HangelGregor KasprianKarl Roessler Original Communication Open access 07 October 2023 Pages: 804 - 818
Effects of pupil size in video head-impulse tests Ho-Jin YoonJeong-Heon LeeJi-Soo Kim Original Communication 08 October 2023 Pages: 819 - 825
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients Rosa De MiccoFederica Di NardoAlessandro Tessitore Original Communication Open access 09 October 2023 Pages: 826 - 834
Current management of primary mitochondrial disorders in EU countries: the European Reference Networks survey Michelangelo MancusoPiervito LoprioreTeresinha Evangelista Original Communication Open access 13 October 2023 Pages: 835 - 840
Intake reminders are effective in enhancing adherence to direct oral anticoagulants in stroke patients: a randomised cross-over trial (MAAESTRO study) Fine DietrichAlexandros A. PolymerisIsabelle Arnet Original Communication Open access 13 October 2023 Pages: 841 - 851
Longitudinal predictors of health-related quality of life in isolated dystonia Johanna JunkerJames HallNorbert Brüggemann Original Communication Open access 15 October 2023 Pages: 852 - 863
Mitochondrial myopathy without extraocular muscle involvement: a unique clinicopathologic profile Yan LinJiayin WangKunqian Ji Original Communication 17 October 2023 Pages: 864 - 876
Clinical outcome after thrombectomy in patients with MeVO stroke: importance of clinical and technical factors Terje NomeBrian EnriquezMona Beyer Original Communication Open access 17 October 2023 Pages: 877 - 886
Subjective and objective responses to caloric stimulation help separate vestibular migraine from other vestibular disorders I. P. HanniganS. M. RosengrenS. R. D. Watson Original Communication Open access 17 October 2023 Pages: 887 - 898
Machine learning using multimodal and autonomic nervous system parameters predicts clinically apparent stroke-associated pneumonia in a development and testing study Alexander NeldeLaura KrummChristian Meisel Original Communication Open access 18 October 2023 Pages: 899 - 908
Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort Viktoria L. K. SchaeffPia S. SperberThomas G. Liman Original Communication Open access 18 October 2023 Pages: 909 - 917
Cognitive impairment associated with cerebellar volume loss in spinocerebellar ataxia type 3 Zhi-Xian YeJin BiOSCCAR Investigators Original Communication 18 October 2023 Pages: 918 - 928
Disease survival and progression in TARDBP ALS patients from Sardinia, Italy Giuseppe BorgheroFrancesca PiliGiovanni Defazio Original Communication 19 October 2023 Pages: 929 - 934
Recurrence and long-term outcomes of Tolosa-Hunt syndrome Hyun-Jae KimSun-Uk LeeJi-Soo Kim Original Communication 19 October 2023 Pages: 935 - 943
Cardiac sympathetic “morbidity” might reflect the neurobiology of early Parkinson’s disease Sang-Won YooYoon-Sang OhJoong-Seok Kim Original Communication 21 October 2023 Pages: 944 - 954
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis Barbara IazzolinoMaurizio GrassanoAdriano Chiò Original Communication Open access 25 October 2023 Pages: 955 - 961
Gray matter loss relates to dual task gait in Lewy body disorders and aging Arsenije SuboticMyrlene GeeCanadian Consortium on Neurodegeneration in Aging (CCNA) Original Communication 30 October 2023 Pages: 962 - 975
Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson’s disease Weimin LiHao WuGanqiang Liu Original Communication 30 October 2023 Pages: 976 - 985
Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3 Carlos Pablo de Fuenmayor-Fernández de la HozVincenzo LupoCristina Domínguez-González Original Communication 31 October 2023 Pages: 986 - 994
Yield of non-invasive imaging in MRI-negative focal epilepsy Christian CzarnetzkiLaurent SpinelliMargitta Seeck Original Communication Open access 01 November 2023 Pages: 995 - 1003
Differentiation of speech in Parkinson’s disease and spinocerebellar degeneration using deep neural networks Katsuki EguchiHiroaki YaguchiIchiro Yabe Short Commentary 21 November 2023 Pages: 1004 - 1012
Case report of palatal tremor as a feature of CASPR2 autoimmune encephalitis Giovanna S. ManzanoCaleb McEntireNagagopal Venna Letter to the Editors 11 October 2023 Pages: 1013 - 1014
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report Adolfo Jiménez-HueteAna Patiño-GarcíaNicolás Pérez Letter to the Editors 13 October 2023 Pages: 1015 - 1018
Rapidly progressive moyamoya vasculopathy stabilized with immunotherapy in aicardi-goutières syndrome Jenae VancuraNatalie K. BoydJonathan D. Santoro Letter to the Editors 19 October 2023 Pages: 1019 - 1022
Bilateral vestibulopathy in RFC1-positive CANVAS is distinctly different compared to FGF14-linked spinocerebellar ataxia 27B Max BorscheMirja ThomsenNorbert Brüggemann Letter to the Editors Open access 20 October 2023 Pages: 1023 - 1027
Primary progressive aphasia: six questions in search of an answer Christopher R. S. BelderCharles R. MarshallJason D. Warren Neurological Update Open access 31 October 2023 Pages: 1028 - 1046
Novel biomarkers and neuroimaging techniques in Parkinson’s disease A. SawS. BariNeil P. Robertson Journal club Open access 17 January 2024 Pages: 1056 - 1058
The DeMyers: Marian (1922–2012) and William (1924–2008) Lazaros C. Triarhou Pioneers in Neurology 07 December 2023 Pages: 1059 - 1061
Correction to: Neurological update: non-motor symptoms in atypical parkinsonian syndromes Piriyankan AnanthavarathanB. PatelN. Malek Correction Open access 27 December 2023 Pages: 1062 - 1062